{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:08:13Z","timestamp":1782457693316,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["1R56 AI076345"],"award-info":[{"award-number":["1R56 AI076345"]}]},{"name":"NIH","award":["RO1 AI 22662"],"award-info":[{"award-number":["RO1 AI 22662"]}]},{"name":"NIH","award":["RO1 AI 50668"],"award-info":[{"award-number":["RO1 AI 50668"]}]},{"name":"NIH","award":["RO1 AI082548"],"award-info":[{"award-number":["RO1 AI082548"]}]},{"name":"NIH","award":["P40 RR02512"],"award-info":[{"award-number":["P40 RR02512"]}]},{"name":"Division of Intramural Research, NAID"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.030","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T09:44:27Z","timestamp":1313919867000},"page":"8134-8140","source":"Crossref","is-referenced-by-count":26,"title":["Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"David","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rojelio","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lustigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Nutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.030_bib0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4269\/ajtmh.2010.09-0750","article-title":"Strongyloidiasis-related deaths in the United States, 1991\u20132006","volume":"83","author":"Croker","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","article-title":"Strongyloides stercoralis in the immunocompromised population","volume":"17","author":"Keiser","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11908-008-0019-6","article-title":"Strongyloides stercoralis infection in the immunocompromised host","volume":"10","author":"Ramanathan","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0020","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1371\/journal.pntd.0000456","article-title":"T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen","volume":"3","author":"Montes","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2011.08.030_bib0025","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1017\/S0031182000007290","article-title":"Albendazole: a review of anthelmintic efficacy and safety in humans","volume":"121","author":"Horton","year":"2000","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1254\/fpj.122.527","article-title":"Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy","volume":"122","author":"Ikeda","year":"2003","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2009.11.001","article-title":"Unresolved issues in anthelmintic pharmacology for helminthiases of humans","volume":"40","author":"Geary","year":"2010","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0040","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1371\/journal.pntd.0000998","article-title":"Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus","volume":"5","author":"Osei-Atweneboana","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0065-308X(10)73010-4","article-title":"Control of important helminthic infections vaccine development as part of the solution","volume":"73","author":"Bergquist","year":"2010","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.provac.2010.11.003","article-title":"Multivalent vaccine for lymphatic filariasis","volume":"3","author":"Samykutty","year":"2010","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0055","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1096\/fj.05-3936fje","article-title":"Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals","volume":"19","author":"Bethony","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0060","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.vaccine.2008.02.049","article-title":"Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults","volume":"26","author":"Bethony","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0065","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/infdis\/174.6.1380","article-title":"Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae","volume":"174","author":"Ghosh","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0070","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1086\/381901","article-title":"Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum","volume":"189","author":"Goud","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0075","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.vaccine.2004.12.022","article-title":"Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum","volume":"23","author":"Mendez","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0080","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/IAI.00848-09","article-title":"Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus","volume":"78","author":"Zhan","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parint.2009.10.009","article-title":"Strongyloides stercoralis and the immune response","volume":"59","author":"Iriemenam","year":"2010","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/expr.1995.1036","article-title":"Strongyloides stercoralis: protective immunity to third-stage larvae in BALB\/cByJ mice","volume":"80","author":"Abraham","year":"1995","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/expr.1996.0035","article-title":"Strongyloides stercoralis: role of antibody and complement in immunity to the third stage of larvae in BALB\/cByJ mice","volume":"82","author":"Brigandi","year":"1996","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0100","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/382484","article-title":"Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice","volume":"189","author":"Kerepesi","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0105","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1128\/IAI.71.12.6835-6843.2003","article-title":"Specificity and mechanism of immunoglobulin M (IgM)- and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice","volume":"71","author":"Ligas","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0014-4894(02)00008-5","article-title":"Immunoaffinity-isolated antigens induce protective immunity against larval Strongyloides stercoralis in mice","volume":"100","author":"Herbert","year":"2002","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0115","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1128\/IAI.73.4.2298-2305.2005","article-title":"DNA immunization with Na+\u2013K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice","volume":"73","author":"Kerepesi","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-3024.1997.d01-142.x","article-title":"IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis","volume":"19","author":"Rotman","year":"1997","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0135","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/589718","article-title":"A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection","volume":"198","author":"Ramanathan","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0166-6851(94)90122-8","article-title":"Identification and characterization of an Onchocerca volvulus cDNA clone encoding a highly immunogenic calponin-like protein","volume":"65","author":"Irvine","year":"1994","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0166-6851(96)02659-X","article-title":"Identification of novel sequences and codon usage in Strongyloides stercoralis","volume":"79","author":"Moore","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4269\/ajtmh.2005.72.549","article-title":"Strongyloides stercoralis recombinant NIE antigen shares epitope with recombinant Ves v 5 and Pol a 5 allergens of insects","volume":"72","author":"Ravi","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0155","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/CVI.00259-10","article-title":"Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina","volume":"17","author":"Krolewiecki","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1645\/GE-2276.1","article-title":"Vaccination against Strongyloides venezuelensis with homologue antigens using new immunomodulators","volume":"96","author":"Vlaminck","year":"2010","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0165","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1017\/S0031182010000314","article-title":"Proteomic analysis of Strongyloides stercoralis L3 larvae","volume":"137","author":"Marcilla","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0170","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1128\/IAI.01958-05","article-title":"Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval Strongyloides stercoralis in mice","volume":"74","author":"Galioto","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.030_bib0175","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.176.7.4315","article-title":"Complement component C3 is required for protective innate and adaptive immunity to larval Strongyloides stercoralis in mice","volume":"176","author":"Kerepesi","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T02:41:09Z","timestamp":1560480069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11012618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11012618"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}